The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
2.730
-0.050 (-1.80%)
At close: Mar 9, 2026, 4:00 PM EDT
2.740
+0.010 (0.37%)
After-hours: Mar 9, 2026, 7:40 PM EDT

The Oncology Institute Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
26923150123714-
Upgrade
Market Cap Growth
297.65%-84.48%22.52%-82.81%--
Upgrade
Enterprise Value
33899181139808-
Upgrade
Last Close Price
2.780.312.041.659.7510.80
Upgrade
PE Ratio
---1805.81--
Upgrade
PS Ratio
0.570.060.460.493.52-
Upgrade
PB Ratio
-6.512.641.006.86-
Upgrade
P/TBV Ratio
--4.721.4712.05-
Upgrade
EV/Sales Ratio
0.730.250.560.553.98-
Upgrade
Debt / Equity Ratio
-8.4434.342.100.880.000.43
Upgrade
Net Debt / Equity Ratio
-6.1920.500.650.28-1.100.21
Upgrade
Net Debt / EBITDA Ratio
-2.23-1.37-0.68-0.512.71-1.28
Upgrade
Net Debt / FCF Ratio
-2.76-2.43-0.90-0.513.21-8.65
Upgrade
Asset Turnover
2.692.061.381.091.513.00
Upgrade
Inventory Turnover
27.1028.6223.0825.5330.0536.55
Upgrade
Quick Ratio
1.341.883.623.844.550.81
Upgrade
Current Ratio
1.682.154.134.395.171.04
Upgrade
Return on Equity (ROE)
-4132.17%-213.36%-92.20%0.13%-16.52%-40.73%
Upgrade
Return on Assets (ROA)
-14.99%-19.67%-15.97%-19.35%-21.08%-7.81%
Upgrade
Return on Invested Capital (ROIC)
-64.24%-70.31%-47.85%-97.58%-377.00%-18.25%
Upgrade
Return on Capital Employed (ROCE)
-41.90%-49.90%-34.50%-31.00%-26.10%-21.10%
Upgrade
Earnings Yield
-20.86%-276.96%-55.21%0.12%-1.53%-
Upgrade
FCF Yield
-10.50%-129.89%-27.17%-54.80%-4.98%-
Upgrade
Buyback Yield / Dilution
-15.14%-1.76%8.51%-21.70%-12.03%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.